Product catalog antigen listed by alphabetic starting with V
| Items 101 to 200 of 246 total | 3 Page(s): |
Protein
| Catalog No. | Species | Presentation | Purity | Source | |||
|---|---|---|---|---|---|---|---|
| VEGF26-R-10 | Vascular Endothelial Growth Factor A (Isoform165) antigen | ||||||
| Human | Purified | >98% | E. coli | 10 µg / --- | |||
| Alpha Diagnostic Intl. Inc. | |||||||
| PR15030-25 | Vascular Endothelial Growth Factor A (Isoform165) antigen | ||||||
| Human | Purified | >97% | E. coli | 25 µg / --- | |||
| Neuromics Antibodies | |||||||
| PR15031-10 | Vascular Endothelial Growth Factor A (Isoform165) antigen | ||||||
| Human | Purified | >97% | Insect cells | 10 µg / --- | |||
| Neuromics Antibodies | |||||||
| PR15031-50 | Vascular Endothelial Growth Factor A (Isoform165) antigen | ||||||
| Human | Purified | >97% | Insect cells | 50 µg / --- | |||
| Neuromics Antibodies | |||||||
| H00007423-P01-10 | Vascular endothelial growth factor B antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00007423-P01-25 | Vascular endothelial growth factor B antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00007423-Q01-10 | Vascular endothelial growth factor B antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00007423-Q01-25 | Vascular endothelial growth factor B antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00007424-P01-10 | Vascular endothelial growth factor C antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00007424-P01-25 | Vascular endothelial growth factor C antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00007424-Q01-10 | Vascular endothelial growth factor C antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00007424-Q01-25 | Vascular endothelial growth factor C antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| AR01001PU-N | Vascular endothelial growth factor C antigen | ||||||
| Human | Purified | Insect cells | 20 µg / US$ 455 | ||||
| Acris Antibodies GmbH | |||||||
| AR01001PU-S | Vascular endothelial growth factor C antigen | ||||||
| Human | Purified | Insect cells | 5 µg / US$ 275 | ||||
| Acris Antibodies GmbH | |||||||
| DA3519 | Vascular endothelial growth factor C antigen | ||||||
| Rat | Purified | >90% | Insect cells | 5 µg / US$ 275 | |||
| Acris Antibodies GmbH | |||||||
| DA3519X | Vascular endothelial growth factor C antigen | ||||||
| Rat | Purified | >90% | Insect cells | 20 µg / US$ 455 | |||
| Acris Antibodies GmbH | |||||||
| DA3520 | Vascular endothelial growth factor C antigen | ||||||
| Rat | Purified | >90% | Insect cells | 5 µg / US$ 255 | |||
| Acris Antibodies GmbH | |||||||
| DA3520X | Vascular endothelial growth factor C antigen | ||||||
| Rat | Purified | >90% | Insect cells | 20 µg / US$ 375 | |||
| Acris Antibodies GmbH | |||||||
| H00002277-P01-10 | Vascular endothelial growth factor D antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002277-P01-25 | Vascular endothelial growth factor D antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| DA3517 | Vascular Endothelial Growth Factor E (ov-HB-VEGF-E) antigen | ||||||
| Orf Virus | Purified | >90% | E. coli | 5 µg / US$ 315 | |||
| Acris Antibodies GmbH | |||||||
| DA3517X | Vascular Endothelial Growth Factor E (ov-HB-VEGF-E) antigen | ||||||
| Orf Virus | Purified | >90% | E. coli | 20 µg / US$ 495 | |||
| Acris Antibodies GmbH | |||||||
| DA3516 | Vascular Endothelial Growth Factor E (VEGF-E) antigen | ||||||
| Orf Virus | Purified | >90% | E. coli | 5 µg / US$ 335 | |||
| Acris Antibodies GmbH | |||||||
| DA3516S | Vascular Endothelial Growth Factor E (VEGF-E) antigen | ||||||
| Orf Virus | Purified | >90% | E. coli | 2 µg / US$ 235 | |||
| Acris Antibodies GmbH | |||||||
| DA3516X | Vascular Endothelial Growth Factor E (VEGF-E) antigen | ||||||
| Orf Virus | Purified | >90% | E. coli | 20 µg / ask | |||
| Acris Antibodies GmbH | |||||||
| H00002321-Q01-10 | Vascular endothelial growth factor receptor 1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002321-Q01-25 | Vascular endothelial growth factor receptor 1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| DA3532 | Vascular endothelial growth factor receptor 1 antigen | ||||||
| Human | Purified | >85% | Insect cells | 5 µg / US$ 225 | |||
| Acris Antibodies GmbH | |||||||
| DA3532X | Vascular endothelial growth factor receptor 1 antigen | ||||||
| Human | Purified | >85% | Insect cells | 20 µg / US$ 325 | |||
| Acris Antibodies GmbH | |||||||
| DA3541 | Vascular endothelial growth factor receptor 1 (D1-D3) antigen | ||||||
| Human | Purified | >90% | Insect cells | 5 µg / US$ 275 | |||
| Acris Antibodies GmbH | |||||||
| DA3541X | Vascular endothelial growth factor receptor 1 (D1-D3) antigen | ||||||
| Human | Purified | >90% | Insect cells | 20 µg / US$ 405 | |||
| Acris Antibodies GmbH | |||||||
| DA3533 | Vascular endothelial growth factor receptor 1 (D1-D4) antigen | ||||||
| Human | Purified | >60% | Insect cells | 5 µg / US$ 275 | |||
| Acris Antibodies GmbH | |||||||
| DA3533X | Vascular endothelial growth factor receptor 1 (D1-D4) antigen | ||||||
| Human | Purified | >60% | Insect cells | 20 µg / US$ 405 | |||
| Acris Antibodies GmbH | |||||||
| DA3539 | Vascular endothelial growth factor receptor 1 (D1-D5) antigen | ||||||
| Human | Purified | >90% | Insect cells | 5 µg / US$ 225 | |||
| Acris Antibodies GmbH | |||||||
| DA3539X | Vascular endothelial growth factor receptor 1 (D1-D5) antigen | ||||||
| Human | Purified | >90% | Insect cells | 20 µg / US$ 325 | |||
| Acris Antibodies GmbH | |||||||
| DA3534 | Vascular endothelial growth factor receptor 1 (Fc-Chimera) antigen | ||||||
| Human | Purified | >95% | Insect cells | 10 µg / US$ 225 | |||
| Acris Antibodies GmbH | |||||||
| DA3534X | Vascular endothelial growth factor receptor 1 (Fc-Chimera) antigen | ||||||
| Human | Purified | >95% | Insect cells | 50 µg / US$ 395 | |||
| Acris Antibodies GmbH | |||||||
| H00003791-Q01-10 | Vascular endothelial growth factor receptor 2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00003791-Q01-25 | Vascular endothelial growth factor receptor 2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| DA3530 | Vascular endothelial growth factor receptor 2 (D1-7) antigen | ||||||
| Human | Purified | >90% | Insect cells | 5 µg / US$ 225 | |||
| Acris Antibodies GmbH | |||||||
| DA3530X | Vascular endothelial growth factor receptor 2 (D1-7) antigen | ||||||
| Human | Purified | >90% | Insect cells | 50 µg / US$ 495 | |||
| Acris Antibodies GmbH | |||||||
| DA3531 | Vascular endothelial growth factor receptor 2 (D1-7) (Fc-Chimera) antigen | ||||||
| Human | Purified | >90% | Insect cells | 50 µg / US$ 405 | |||
| Acris Antibodies GmbH | |||||||
| DA3531S | Vascular endothelial growth factor receptor 2 (D1-7) (Fc-Chimera) antigen | ||||||
| Human | Purified | >90% | Insect cells | 10 µg / US$ 225 | |||
| Acris Antibodies GmbH | |||||||
| H00002324-Q01-10 | Vascular endothelial growth factor receptor 3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00002324-Q01-25 | Vascular endothelial growth factor receptor 3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| DA3536 | Vascular endothelial growth factor receptor 3 (Fc-Chimera) antigen | ||||||
| Human | Purified | >90% | Insect cells | 10 µg / US$ 255 | |||
| Acris Antibodies GmbH | |||||||
| DA3536X | Vascular endothelial growth factor receptor 3 (Fc-Chimera) antigen | ||||||
| Human | Purified | >90% | Insect cells | 50 µg / US$ 435 | |||
| Acris Antibodies GmbH | |||||||
| DA3535 | Vascular endothelial growth factor receptor 3 (HIS tagged) antigen | ||||||
| Human | Purified | >90% | Insect cells | 10 µg / US$ 305 | |||
| Acris Antibodies GmbH | |||||||
| DA3535S | Vascular endothelial growth factor receptor 3 (HIS tagged) antigen | ||||||
| Human | Purified | >90% | Insect cells | 5 µg / US$ 255 | |||
| Acris Antibodies GmbH | |||||||
| DA3535X | Vascular endothelial growth factor receptor 3 (HIS tagged) antigen | ||||||
| Human | Purified | >90% | Insect cells | 50 µg / US$ 465 | |||
| Acris Antibodies GmbH | |||||||
| H00022846-Q01-10 | Vasohibin-1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00022846-Q01-25 | Vasohibin-1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000552-Q01-10 | Vasopressin V1a Receptor / AVPR V1a (Control Peptide) antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000552-Q01-25 | Vasopressin V1a Receptor / AVPR V1a (Control Peptide) antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00007416-Q01-10 | VDAC1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00007416-Q01-25 | VDAC1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00007417-P01-02 | VDAC2 antigen | ||||||
| Human | in vitro transl. | 2 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00007417-P01-10 | VDAC2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00007417-P01-25 | VDAC2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00007417-P02-10 | VDAC2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00007417-P02-25 | VDAC2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00007419-P01-10 | VDAC3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00007419-P01-25 | VDAC3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| PR15032-5 | VEGF/PIGF Heterodimer antigen | ||||||
| Human | Purified | >97% | E. coli | 5 µg / --- | |||
| Neuromics Antibodies | |||||||
| H00006843-Q01-10 | Vesicle-associated membrane protein 1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00006843-Q01-25 | Vesicle-associated membrane protein 1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| GTX24957 | Vesicle-associated membrane protein 1 antigen | ||||||
| 50 µg / --- | |||||||
| GeneTex Inc. | |||||||
| GTX24958 | Vesicle-associated membrane protein 2 antigen | ||||||
| 50 µg / --- | |||||||
| GeneTex Inc. | |||||||
| H00009341-P01-02 | Vesicle-associated membrane protein 3 antigen | ||||||
| Human | in vitro transl. | 2 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009341-P01-10 | Vesicle-associated membrane protein 3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009341-P01-25 | Vesicle-associated membrane protein 3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00008674-P01-02 | Vesicle-associated membrane protein 4 antigen | ||||||
| Human | in vitro transl. | 2 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00008674-P01-10 | Vesicle-associated membrane protein 4 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00008674-P01-25 | Vesicle-associated membrane protein 4 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010791-Q01-10 | Vesicle-associated membrane protein 5 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010791-Q01-25 | Vesicle-associated membrane protein 5 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00006845-Q01-10 | Vesicle-associated membrane protein 7 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00006845-Q01-25 | Vesicle-associated membrane protein 7 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00008673-P01-10 | Vesicle-associated membrane protein 8 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00008673-P01-25 | Vesicle-associated membrane protein 8 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009218-P01-02 | Vesicle-associated membrane protein-associated protein A antigen | ||||||
| Human | in vitro transl. | 2 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009218-P01-10 | Vesicle-associated membrane protein-associated protein A antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009218-P01-25 | Vesicle-associated membrane protein-associated protein A antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009217-P01-10 | Vesicle-associated membrane protein-associated protein B/C antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00009217-P01-25 | Vesicle-associated membrane protein-associated protein B/C antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00006572-Q01-10 | Vesicular acetylcholine transporter antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00006572-Q01-25 | Vesicular acetylcholine transporter antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| BP207CP | Vesicular Acetylcholine Transporter - control peptide antigen | ||||||
| Rat | >80% | Synthetic | 50 µg / US$ 285 | ||||
| Acris Antibodies GmbH | |||||||
| H00007429-Q01-10 | Villin-1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00007429-Q01-25 | Villin-1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00007431-Q01-10 | Vimentin antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00007431-Q01-25 | Vimentin antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| BA1017 | Vimentin antigen | ||||||
| Human | Purified | >98% | E. coli | 0.25 mg / ask | |||
| Acris Antibodies GmbH | |||||||
| PA1377 | Vimentin antigen | ||||||
| Human | Purified | - | E. coli | 2 µg / US$ 225 | |||
| Acris Antibodies GmbH | |||||||
| PA1377X | Vimentin antigen | ||||||
| Human | Purified | - | E. coli | 10 µg / US$ 305 | |||
| Acris Antibodies GmbH | |||||||
| PA1377XC | Vimentin antigen | ||||||
| Human | Purified | - | E. coli | 1 mg / ask | |||
| Acris Antibodies GmbH | |||||||
| H00007414-P01-10 | Vinculin antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00007414-P01-25 | Vinculin antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00007433-Q01-10 | VIP Receptor 1 / VIPR1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00007433-Q01-25 | VIP Receptor 1 / VIPR1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00007434-P01-10 | VIP Receptor 2 / VIPR2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| Items 101 to 200 of 246 total | 3 Page(s): |


